ASCVD	Atherosclerotic cardiovascular disease
BMI	Body mass index
BNP	Brain natriuretic peptide
cAMP	Cyclic adenosine monophosphate
CI	Confidence interval
CKD	Chronic kidney disease
CR	Cardiac rehabilitation
CV	Cardiovascular
CVD	Cardiovascular disease
CVOTs	Cardiovascular outcome trials
DM	Diabetes mellitus
DPP-4	Dipeptidyl peptidase-4
eGFR	Estimated glomerular filtration rate
ET-1	Endothelin-1
GI	Gastrointestinal
GLP-1	Glucagon-like peptide-1
GLP-1R	Glucagon-like peptide-1 receptor
GLP-1RAs	Glucagon-like peptide-1 receptor agonists
HF	Heart failure
HFpEF	Heart failure with preserved ejection fraction
HFrEF	Heart failure with reduced ejection fraction
HR	Hazard ratio
KCCQ	Kansas City Cardiomyopathy Questionnaire
LV	Left ventricle
LVEF	Left ventricular ejection fraction
MACE	Major cardiovascular events
MAPK	Mitogen-activated protein kinase
MI	Myocardial infarction
NO	Nitric oxide
NT pro-BNP	N-terminal pro-brain natriuretic peptide
PI3K	Phosphatidylinositol-3-kinase
PKA	Protein kinase A
QOL	Quality of life
RCTs	Randomized controlled trials
RR	Relative risk
SGLT2	Sodium glucose transporter-2
T2DM	Type 2 diabetes mellitus
VO2	Volume of oxygen